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James O. Menzoían, MD, Book Review Section Editor
Comprehensive vascular and endovascular surgery
John W. Hallett, Jr, Joseph L. Mills, Jonothan J. Earnshaw,
and Jim Reekers; Toronto, 2004; Mosby; 712 pages.
This vascular textbook is relevant to modern clinical practice
because of its up-to-date details and is useful for surgical educators
because of its thoughtful organization. The editors are to be
commended for an excellent addition to the surgical literature. It is
clearly illustrated with a consistent graphic style for the depiction of
procedures and the presentation of tables and algorithms. The
illustrations are all provided in an accompanying compact disc for
use in teaching seminars.
At present there is a need to explain to the student of vascular
surgery the essential knowledge necessary for the care of vascular
patients while indicating when endovascular therapies are to be
preferred to open surgical procedures and vice versa. Comprehen-
sive Vascular and Endovascular Surgery addresses this need by
predicating the organization of the text on the evolving dynamic of
therapeutic choices. In their preface, the editors put forth their
vision of a textbook that represents the collaboration and commu-
nication of all of the specialists who participate in the care of the
patient with vascular disease. The editors have also attempted to lay
the groundwork for future editions that incorporate an improved
understanding of pathophysiology and knowledge of the best
clinical trials.
Many open surgical techniques will become rarely used pro-
cedures, but their origin in the understanding of vascular patho-
physiology and their effects on vascular disease have provided the
insights on which our specialty is based. I was pleased to see that
the modern practice of vascular surgery could be so successfully
conceptualized. The unifying effect of the illustrations is a re-
minder throughout that the cognitive aspects of our discipline
define us as a specialty.
This volume, which is produced by respected practitioners
from the United States, England, and The Netherlands, is orga-
nized into 10 sections. Section I presents the historical basis of
vascular surgery and the role of evidence-based medicine in the
improvement of therapies for vascular disease. Chapters on vascu-
lar biology, thrombosis and hemostasis, and hemodynamics com-
plete this section. The remaining 9 sections cover vascular disease
of the extremities and the viscera, and cerebrovascular and venous
disease.
The chapters in each section are organized around the clinical
approach to the vascular diseases defined in the section title. For
example, “Section 2: Claudication” is composed of chapters on
noninvasive laboratory evaluation of lower extremity occlusive
disease and the medical, interventional, and surgical management
of patients with claudication. This presentation differs from the
traditional textbook approach to peripheral arterial disease of the
lower extremity in that the information provided in each of these
chapters is referable exclusively to themanagement of claudication.
More severe ischemia of the legs is taken up in the next section.
Here, in “Section 3: Chronic Lower Extremity Ischemia,” the
modern management of critical limb ischemia is the focus of the
next 5 chapters and 102 pages. I found this organization of
information very readable, and as I encountered each subsequent
section, I came to appreciate the value of relating advances and
controversies in the context of the clinical problem identified by
the section.
Other reviewers have lamented the redundancy of information
in textbooks of vascular surgery, and obvious care has been taken to
eliminate repetition of information in this new textbook. Subse-
quent sections on acute limb ischemia, upper extremity problems,
mesenteric syndromes, and renovascular, aneurysmal, cerebrovas-
cular, and venous disease each include relevant information that
might have been provided in separately titled chapters. In other
textbooks, one finds oneself searching through several chapters on
pharmacotherapy, angiography, and ultrasonography, for exam-
ple, to sort out management options for a single problem.
I troubled over the “comprehensive” in the title of this book
because other textbooks are much larger and contain more infor-
mation about vascular disease. After reading this new textbook, I
believe that it is appropriately titled in that it attempts to compre-
hensively describe each clinical entity selected for inclusion in the
text and that, indeed, this is the organizing principle of the book.
I believe that this organization is quite useful to the student of
vascular surgery and most closely parallels clinical thinking. I think
that the text is particularly useful for practicing vascular surgeons
who organize their thought processes around the therapeutic
options available to them. I am sure that vascular surgeons and
program directors will find this new addition to the vascular
literature helpful to their practice and useful in their role as surgical
educators.
It is also clear from such a text that today’s vascular surgical
specialists should have at their command all of the therapies
described in this book, and, as such, I believe that it meets its
objective of representing the modern practice of vascular and
endovascular surgery. I look forward to future editions in which
the effect of outcomes research more clearly defines our choice of
options in the treatment of vascular disease.
John J. Castronuovo, Jr, MD, FACS
Chair, Division of Vascular Surgery
Morristown Memorial Hospital
Morristown, NJ
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The truth about the drug companies: How they
deceive us and what to do about it
Marcia Angell, MD; New York, NY, 2004; Random House;
305 pages; $24.95.
Although aimed at the lay public, this book merits reading by
all physicians and health care professionals who are involved with
prescribing drugs. It is based on an article, “American’s Other
Drug Problem—The Insatiable Greed of the Pharmaceutical In-
dustry,” that appeared in the New Republic in 2002. The author
and her husband, both former editors of theNew England Journal
of Medicine, received the George Polk Award for this article.
In the book, Dr. Marcia Angell, armed with well-researched
facts and sound documentation, critically evaluates the drug indus-
try, termed “big pharma.” Central themes are that big pharma:
1 reaps massive profits (has consistently ranked as the most prof-
itable industry listed in the Fortune 500);
2 spends a relatively paltry amount on the development of new
drugs (most of the creative and scientific work leading to new
“breakthrough” medicines is done by NIH-funded university
laboratories);
3 devotes a great deal of effort to develop minor modifications of
highly successful and profitable drugs (creates “me too” drugs)
in order to extend exclusive marketing rights;
4 spends large amounts of money on frivolous legal maneuvering
to extend patent rights on blockbuster drugs before they be-
come generic (the profits produced by extending exclusive
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